eTable 3. The effect of combined oral contraceptives on breast cancer risk*1.
Study | Number | Relative risk | 95% CI | |
Cases | Controls | |||
Oxford reanalysis, 1996 (19) | 53 297 | 100 239 | Current/previous COC: 1.24 | 1.15–1.33 |
Nurses’ Health Study, 1997 (cohort study) (e43) | 3383 | 1.11 COC >5 years: 0.96 | 0.94–1.32 | |
0.65–1.43 | ||||
Women’s CARE Study, 2002 (e44) | 4575 | 4682 | 1.0 | 0.8–1.1 |
Women’s Lifestyle and Health Study, 2002 (cohort study) (e45) | 103 027 | Previous COC: 1.2 C | 1.1–1.4 | |
urrent/previous COC: 1.6 | 1.2–2.0 | |||
Mayo Clinic (metaanalysis), 2006 (e46) | Premenopausal breast cancer | Current/previous COC: 1.19 | 1.09–1.29 | |
Oxford Family Planning Association Study, 2006 (cohort study) (18) | 17 032 | 1.0 | 0.8–1.1 | |
Royal College of General Practitioners’ Study. 2007 (cohort study) (17) | 46 000 (744 000 woman years) | 0.98 | 0.87–1.1 |
COC, combined preparations; CI, confidence interval;
*1data from (20)